392 related articles for article (PubMed ID: 35949115)
1. Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.
Costantini A; Mäkitie RE; Hartmann MA; Fratzl-Zelman N; Zillikens MC; Kornak U; Søe K; Mäkitie O
J Bone Miner Res; 2022 Sep; 37(9):1623-1641. PubMed ID: 35949115
[TBL] [Abstract][Full Text] [Related]
2. Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).
Stürznickel J; Rolvien T; Delsmann A; Butscheidt S; Barvencik F; Mundlos S; Schinke T; Kornak U; Amling M; Oheim R
J Bone Miner Res; 2021 Feb; 36(2):271-282. PubMed ID: 33118644
[TBL] [Abstract][Full Text] [Related]
3. More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A.
Caetano da Silva C; Ricquebourg M; Orcel P; Fabre S; Funck-Brentano T; Cohen-Solal M; Collet C
Mol Genet Genomic Med; 2021 Jun; 9(6):e1681. PubMed ID: 33939331
[TBL] [Abstract][Full Text] [Related]
4. Bone fragility and osteoporosis in children and young adults.
Formosa MM; Christou MA; Mäkitie O
J Endocrinol Invest; 2024 Feb; 47(2):285-298. PubMed ID: 37668887
[TBL] [Abstract][Full Text] [Related]
5. Early-Onset Osteoporosis.
Mäkitie O; Zillikens MC
Calcif Tissue Int; 2022 May; 110(5):546-561. PubMed ID: 34236445
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
[TBL] [Abstract][Full Text] [Related]
7. Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.
Oheim R; Tsourdi E; Seefried L; Beller G; Schubach M; Vettorazzi E; Stürznickel J; Rolvien T; Ehmke N; Delsmann A; Genest F; Krüger U; Zemojtel T; Barvencik F; Schinke T; Jakob F; Hofbauer LC; Mundlos S; Kornak U
J Clin Endocrinol Metab; 2022 Jun; 107(7):e3048-e3057. PubMed ID: 35276006
[TBL] [Abstract][Full Text] [Related]
8. Lrp5 Mutant and Crispant Zebrafish Faithfully Model Human Osteoporosis, Establishing the Zebrafish as a Platform for CRISPR-Based Functional Screening of Osteoporosis Candidate Genes.
Bek JW; Shochat C; De Clercq A; De Saffel H; Boel A; Metz J; Rodenburg F; Karasik D; Willaert A; Coucke PJ
J Bone Miner Res; 2021 Sep; 36(9):1749-1764. PubMed ID: 33957005
[TBL] [Abstract][Full Text] [Related]
9. New Insights Into Monogenic Causes of Osteoporosis.
Mäkitie RE; Costantini A; Kämpe A; Alm JJ; Mäkitie O
Front Endocrinol (Lausanne); 2019; 10():70. PubMed ID: 30858824
[TBL] [Abstract][Full Text] [Related]
10. WNT11, a new gene associated with early onset osteoporosis, is required for osteoblastogenesis.
Caetano da Silva C; Edouard T; Fradin M; Aubert-Mucca M; Ricquebourg M; Raman R; Salles JP; Charon V; Guggenbuhl P; Muller M; Cohen-Solal M; Collet C
Hum Mol Genet; 2022 May; 31(10):1622-1634. PubMed ID: 34875064
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.
Cohen A; Hostyk J; Baugh EH; Buchovecky CM; Aggarwal VS; Recker RR; Lappe JM; Dempster DW; Zhou H; Kamanda-Kosseh M; Bucovsky M; Stubby J; Goldstein DB; Shane E
Bone; 2022 Jan; 154():116253. PubMed ID: 34743040
[TBL] [Abstract][Full Text] [Related]
12. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O
Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388
[TBL] [Abstract][Full Text] [Related]
13. Identifying Rare Genetic Determinants for Improved Polygenic Risk Prediction of Bone Mineral Density and Fracture Risk.
Lu T; Forgetta V; Zhou S; Richards JB; Greenwood CM
J Bone Miner Res; 2023 Dec; 38(12):1771-1781. PubMed ID: 37830501
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis.
Hu J; Lin X; Gao P; Zhang Q; Zhou B; Wang O; Jiang Y; Xia W; Xing X; Li M
J Clin Endocrinol Metab; 2023 Jun; 108(7):1776-1786. PubMed ID: 36595228
[TBL] [Abstract][Full Text] [Related]
15. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.
Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O
J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485
[TBL] [Abstract][Full Text] [Related]
16. Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults.
Mäkitie RE; Haanpää M; Valta H; Pekkinen M; Laine CM; Lehesjoki AE; Schalin-Jäntti C; Mäkitie O
J Bone Miner Res; 2016 Sep; 31(9):1734-42. PubMed ID: 27005318
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.
Butscheidt S; Delsmann A; Rolvien T; Barvencik F; Al-Bughaili M; Mundlos S; Schinke T; Amling M; Kornak U; Oheim R
Osteoporos Int; 2018 Jul; 29(7):1643-1651. PubMed ID: 29594386
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2.
Pekkinen M; Terhal PA; Botto LD; Henning P; Mäkitie RE; Roschger P; Jain A; Kol M; Kjellberg MA; Paschalis EP; van Gassen K; Murray M; Bayrak-Toydemir P; Magnusson MK; Jans J; Kausar M; Carey JC; Somerharju P; Lerner UH; Olkkonen VM; Klaushofer K; Holthuis JC; Mäkitie O
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779713
[TBL] [Abstract][Full Text] [Related]
19. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
[TBL] [Abstract][Full Text] [Related]
20. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
